Difference between revisions of "Team:SCUT-China B/Overview"
Charlottte (Talk | contribs) |
Charlottte (Talk | contribs) |
||
| Line 497: | Line 497: | ||
<div class="click" id="btm1"> | <div class="click" id="btm1"> | ||
<img src="https://static.igem.org/mediawiki/parts/f/f6/Wiki_C.png" class="locat"> | <img src="https://static.igem.org/mediawiki/parts/f/f6/Wiki_C.png" class="locat"> | ||
| − | <a href=" | + | <a href="https://2016.igem.org/Team:SCUT-China_B/Overview"><br/>Overview</a> |
</div> | </div> | ||
<div class="click" id="btm2"> | <div class="click" id="btm2"> | ||
<img src="https://static.igem.org/mediawiki/parts/f/f6/Wiki_C.png" class="locat"> | <img src="https://static.igem.org/mediawiki/parts/f/f6/Wiki_C.png" class="locat"> | ||
| − | <a href=" | + | <a href="https://2016.igem.org/Team:SCUT-China_B/Propoptosis">Apoptosis Induction</a> |
</div> | </div> | ||
<div class="click" id="btm3"> | <div class="click" id="btm3"> | ||
<img src="https://static.igem.org/mediawiki/parts/f/f6/Wiki_C.png" class="locat"> | <img src="https://static.igem.org/mediawiki/parts/f/f6/Wiki_C.png" class="locat"> | ||
| − | <a href=" | + | <a href="https://2016.igem.org/Team:SCUT-China_B/Protumor">Tumor specific promoter</a> |
</div> | </div> | ||
</div> | </div> | ||
Revision as of 18:11, 28 November 2016
Non-small cell lung cancer (NSCLC)
While Lung cancer is a common kind of cancer, non-small cell lung cancer belongs to lung cancer and takes the percentage of 80%-85% .Unlike most lung cancer , non-small cell cancer usually appears to occur in people who do not smoke.
According to the WHO Health statistics [1], the death rate of lung cancer is on the top among cancers. In particular, it is the leading cause of cancer death among males in both developed and undeveloped countries.
Figure 1. Death rate among cancers around the world, according to WHO Health statistics.
Therapy for NSCLC
Figure 2. According to Nccn clinical practice guidelines in oncology, non-small cell cancer. Current therapy for NSCLC[2], mainly consists of traditional therapy, small-molecule targeted drugs and cancer immunotherapy.
